| Document Date: 2012-02-28 14:12:37
Open Document File Size: 153,33 KBShare Result on Facebook
City Reference / / Company Merck & Co. Inc. / Merck Sharp & Dohme Corp. / / Currency pence / / IndustryTerm chemical assay / Prevention of Coronary Heart Disease / / MarketIndex set 30 / / MedicalCondition obstructive liver disease / atherosclerotic vascular disease / HIV / myopathy / mixed hyperlipidemia / well-controlled noninsulin dependent diabetes mellitus / primary hypercholesterolemia / Coronary Atherosclerosis / poorly controlled diabetes mellitus / unstable angina / Heterozygous Familial Hypercholesterolemia MEVACOR / Myopathy/Rhabdomyolysis / psoriasis / myoglobinuria / coronary heart disease / Coronary Heart Disease MEVACOR / Familial Hypercholesterolemia / Texas Coronary Atherosclerosis Prevention Study / Heterozygous Familial Hypercholesterolemia / alcoholism / sepsis / hypotension / hypertension / symptomatic cardiovascular disease / CHD / disease / non-familial hypercholesterolemia / atherosclerosis / sudden cardiac death / hypothyroidism / atherogenesis / hypertriglyceridemia / chronic / dyslipidemia / stroke / premature cardiovascular disease / cardiovascular disease / diabetes / severe renal insufficiency / Rhabdomyolysis / hyperlipoproteinemia / nephrotic syndrome / renal insufficiency / carotid atherosclerosis / myocardial infarction / diabetes mellitus / epilepsy / renal failure / acute renal failure / hypercholesterolemia / disorders / / MedicalTreatment percutaneous transluminal coronary angioplasty / diet therapy / bypass / major surgery / drug therapy / heart transplant / / Organization Air Force / / / Position General / Major / representative / / Product Itraconazole / cyclosporine / niacin / MEVACOR / Gemfibrozil / clarithromycin / erythromycin / ketoconazole / LOVASTATIN / Cholestyramine / / PublishedMedium Baseline / / Technology Pharmacokinetics / CVD / /
SocialTag |
[removed]TABLETS MEVACOR® (LOVASTATIN)